title: Editorial commentary: the conundrum of Lamivudine and tenofovir disoproxil fumarate for hepatitis B: fetus versus infant.
authors.affiliation: Pediatric Hepatology and Pediatric Clinical Research, Department of Pediatrics, School of Medicine, University of California, San Francisco.
authors.forename: Philip
authors.initials: P
authors.lastname: Rosenthal
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives*; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D001942:Breast Feeding; D018562:Disease Transmission, Infectious / Q000517:prevention & control*; D005260:Female; D006509:Hepatitis B / Q000188:drug therapy* / Q000517:prevention & control*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D063065:Organophosphonates / Q000627:therapeutic use*; D011247:Pregnancy
chemical_list: D019380:Anti-HIV Agents; D063065:Organophosphonates; D019259:Lamivudine; D000225:Adenine
keywords: breastfeeding; hepatitis B; lamivudine; pregnancy; tenofovir disoproxil fumarate